Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shengbo Zhu
Elevated Serum Visfatin Levels Are Associated With Poor Prognosis of Hepatocellular Carcinoma
Oncotarget
Oncology
Related publications
Elevated Levels of Serum Urokinase Plasminogen Activator Predict Poor Prognosis in Hepatocellular Carcinoma After Resection
BMC Cancer
Cancer Research
Oncology
Genetics
Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Elevated Serum LAMC2 Is Associated With Lymph Node Metastasis and Predicts Poor Prognosis in Penile Squamous Cell Carcinoma
Cancer Management and Research
Oncology
Overexpression of RHEB Is Associated With Metastasis and Poor Prognosis in Hepatocellular Carcinoma
Oncology Letters
Cancer Research
Oncology
Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Serum Bioavailable, Rather Than Total, 25‐hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival
Hepatology
Medicine
Hepatology
Upregulation of E2F Transcription Factor 3 Is Associated With Poor Prognosis in Hepatocellular Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Low Levels of Tumor Suppressor Candidate 3 Predict Poor Prognosis of Patients With Hepatocellular Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Positive Expression of SMYD2 Is Associated With Poor Prognosis in Patients With Primary Hepatocellular Carcinoma
Journal of Cancer
Oncology
